Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the United States and internationally. The company's products include INGREZZA for ...
Q2 2026
Jul 29, 2026
Q1 2026
May 5, 2026
FY 2025
Feb 11, 2026
Q4 2025
Q3 2025
Oct 28, 2025
